BEC5 articles

BEC5 keeps skin cancer at bay
If you have a non-melanoma skin cancer consider treating it with BEC5 Cream

BEC5 keeps skin cancer at bay

What is BEC5 cream?

BEC5 cream is a clinically proven topical treatment for non-melanoma skin cancers. Less painful, non-disfiguring and significantly less expensive than conventional surgery, BEC5 cream also eliminates the need for radiotherapy, chemotherapy or lazer treatments.

BEC5 cream is 99.8 per cent natural, its active ingredients derived from a native Australian plant called “Devils Apple” – or Solanum Sodomaeum. The active constituent used in BEC5 cream – Solasodine Glycosides – is also found in eggplant. BEC5 cream is one of the few natural products that have undergone pharmaceutical grade research and development, having been trialled extensively in Australia and Great Britain.

Dermatologists at the Royal London Hospital said: “BEC5 is a topical preparation which is safe and effective, an ideal therapy for outpatient treatment…It is a cost effective treatment for both primary and secondary skin cancer care.”

How does BEC5 cream work?

BEC5 cream destroys cancer cells without affecting the normal cells. BEC5 treats cancer on the surface of the skin, while also penetrating to attack the whole cancer hidden beneath the skin tissue. BEC5 contains a plant sugar called rhamnose, which binds to the cancer cells. This then enters the cancer cell and destroys its “stomach” (lysosome).

BEC5 is a major medical breakthrough because it destroys only cancer cells. Healthy cells are untouched. Moreover, it does so without scaring or leaving unsightly gaps from loss of skin tissue, as surgery does.

Who is at risk of skin cancer?

Hem lines and hairstyles may come and go, but a “healthy” tan never seems to be out of fashion. Unfortunately, exposing ourselves to the sun puts us at risk of long-term skin damage and skin cancer. In fact, skin cancer is the most common form of cancer in the United States.

Anyone can get skin cancer, but it is more common in people who

• Spend a lot of time in the sun or have been sunburned;

• Have light-coloured skin, hair or eyes;

• Have a family member with skin cancer;

• Are over age 50.

The two most common types of skin cancer are basal cell carcinomas and squamous cell carcinomas. Melanoma is more dangerous but less common. If untreated it can spread to other tissues and organs.

What are the disadvantages of conventional treatments?

Surgery to treat skin cancer usually involves removing the tumour. Treatment requires anaesthesia and possibly skin grafting. Any surgical intervention carries its own risks, plus it may also involve costly reconstructive surgery.

Radiotherapy can result in depressed and depigmented (loss of skin pigment) scar tissue, which may go on to develop degenerative and malignant changes further down the line.

Dermatological treatment may be used for superficial skin cancers, and may vary from scraping out the tumour to fixing the lesion chemically, and shaving it off in layers. With most forms of dermatological therapy, there is a certain amount of pain involved, plus limitations such as:

• Formation of scar tissue;

• Lack of normal tissue regrowth;

• Limited access to the lesion if it is deep within the skin;

• A high rate of recurrence.

How effective is BEC5 cream?

Extensive medical research in Australia and Great Britain over the past 20 years and the testimonials of over 80,000 people confirm that BEC5 cream really works! In one open study with 72 patients, treatment with BEC5 cream resulted in the regression of all treated lesions, with 100% healed after one to 13 weeks of treatment.

Recent trials in 10 UK hospitals have been equally successful. Researchers found that a twice daily topical application of BEC5 cream produced a complete remission in 78 per cent of the patients within eight weeks. The remaining 22 per cent had also improved and needed longer treatment times. All this was made possible without chemotherapy, radiotherapy or surgery.

Furthermore, biopsies taken before, during and after treatment show that BEC5 continued to work five years after therapy ceased, with no return of skin cancer lesions.

The pictures above show a skin cancer lesion before, during and after treatment with BEC5 cream.

The pictures above show a large skin cancer lesion on the temple before and after treatment with BEC5 cream. This had been surgically removed and skin grafts applied on two previous occasions, only to return. Just four weeks’ treatment with BEC5 resulted in full regression with no recurrence after five years.

Is BEC5 cream beneficial for anything else?

BEC5 cream is primarily effective in the treatment of malignant skin cancers, such as non-melanoma basal cell carcinoma and squamous cell carcinoma, however it is also recommended for use on keratoses.

Keratoses are areas of skin that have become discoloured, thickened or scaly as a result of exposure to the sun (UV) light. Solar keratoses occasionally regress if sun exposure is stopped before they become too established. Although non-malignant, they are potentially malignant and can develop into cancer.

How should BEC5 cream be used?

The area to be treated should be cleaned with a mild antiseptic to remove old skin cells. BEC5 cream should then be applied fairly thickly to the area, at least twice daily, and a micro pore placed over the area. Avoid contact with eyes. If any excess occurs, it should be washed and wiped away with cold water.

Continue using BEC5 cream for a minimum of seven days and a maximum of 60 days, depending on the size and nature of the lesion.

Do not apply BEC5 cream to moles and melanomas. A 20ml bottle of BEC5 cream should be enough to treat one large skin cancer, two medium sized ones, six small ones or 12 sun spots.

Are there any side effects?

The only side effect reported from using BEC5 cream is skin reddening, although during treatment, erosion, ulceration and shedding of unwanted skin cells is also likely to take place.

People who are allergic to eggplant or aspirin should not use BEC5 cream.

If you have a non-melanoma skin cancer consider treating it with BEC5 Cream

BEC5 is a topical cream that contains a specially purified plant extract from the Solanum Sodomaeum, or Devil's Apple found in Australasia. The extract, known as Solasodine Glycosides, (0.005%) is also found in smaller quantities in eggplant (aubergine).

BEC5 was formulated as a result of two decades of research and clinical trials.  Biochemist Dr. Cham discovered that when applied topically, BEC5 could eradicate non-melanoma skin cancers, more specifically:-

• Basal cell carcinomas (BCC)
• Squamous cell carcinomas (SCC)

It has also proved very beneficial in treating benign tumors, including:-

• Keratoses
• Keratoacanthomas
• Sun spots
• Age spots

"Not only was the cream totally free from any biochemical or clinical side effects, it also proved to be 100% effective in the prevention and treatment of solar keratoses, basal cell carcinoma and squamous cell carcinoma..."  Dr. Bill Cham

Numerous clinical trials in Australia and Great Britain have confirmed BEC5's curative ability to regress non-melanoma skin cancers.  One open study of 72 patients, culminated in the regression of all treated lesions (56 actinic keratoses, 39 BCCs and 29 SCCs), which were healed completely after 1 to 13 weeks of treatment.

Trials in 10 UK hospitals found that in 78% of patients, twice daily topical applications of BEC5 resulted in complete remissions within 8-weeks; with the remaining 22% requiring longer treatment times.

Royal London Hospital dermatologists concluded that: "BEC5 is a topical preparation that is safe and effective, an ideal therapy for outpatient treatment... It is a cost effective treatment for both primary and secondary skin cancer care."

BEC5 contains a plant sugar called Rhamnose, (which is not usually found in mammalian species). Specific endogenous lectins, (receptors for the sugar part of the glycoalkaloids) are present in the plasma membranes of susceptible cancer cells, but are not present in normal cells. BEC5 recognizes and binds the sugar Rhamnose of the glycoalkaloid to the cancer cell, after which it enters the cancer cell resulting in cell death.

BEC5 is non toxic, non mutagenic, and does not interfere with heartbeat or blood flow.
Additionally, studies have demonstrated no adverse effects on the liver, kidneys or blood cells both during and after treatment.